0001213900-21-022719 4 1 20210321 20210423 20210423 Kohavi Lior 0001762896 4 34 000-26495 21849913 C/O CYREN INC., 1430 SPRING HILL ROAD, SUITE 330 MCLEAN VA 22102 CYREN Ltd. 0001084577 7372 000000000 L3 1231 1 SAPIR ROAD 5TH FLOOR, BEIT AMPA P.O. BOX 4014 HERZLIYA L3 46140 7037603320 C/O CYREN INC. 1430 SPRING HILL ROAD, SUITE 330 MCLEAN VA 22102 COMMTOUCH SOFTWARE LTD 19990419 4 1 ownership.xml FORM 4 OMB APPROVAL [ ] Check this OMB Number: box if no longer UNITED STATES SECURITIES AND EXCHANGE COMMISSION 3235-0287 subject to Washington, D.C. 20549 Estimated Section 16. Form STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF average burden 4 or Form 5 SECURITIES hours per obligations may response... 0.5 continue. See Instruction 1(b). Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 1. Name and Address of Reporting 2. Issuer Name and Ticker 5. Relationship of Person * or Trading Symbol Reporting Person(s) to Kohavi Lior CYREN Ltd. [ CYRN ] Issuer (Check all applicable) _____ Director _____ 10% Owner __X__ Officer (give title (Last) (First) (Middle) 3. Date of Earliest below) _____ Other C/O CYREN INC.,, 1430 SPRING HILL Transaction (MM/DD/YYYY) (specify below) ROAD, SUITE 330 3/21/2021 CSO & EVP, Advanced Solutions (Street) 4. If Amendment, Date 6. Individual or MCLEAN, VA 22102 Original Filed Joint/Group Filing (Check (City) (State) (Zip) (MM/DD/YYYY) Applicable Line) _X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security 2. Trans. Date 2A. 3. Trans. 4. Securities Acquired (A) 5. Amount of 6. Ownership 7. Nature of (Instr. 3) Deemed Code or Disposed of (D) Securities Form: Direct (D) Indirect Execution (Instr. 8) (Instr. 3, 4 and 5) Beneficially or Indirect (I) Beneficial Date, if Owned Following (Instr. 4) Ownership any Reported (Instr. 4) Transaction(s) (A) (Instr. 3 and 4) or Code V Amount (D) Price Ordinary Shares 3/21/2021 A 650000 (1) A $0.00 829027 D Ordinary Shares 24524 I By spouse Ordinary Shares 50000 I By Trust (2) Ordinary Shares 50000 I By Trust (2) Ordinary Shares 50000 I By Trust (2) Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) 1. Title of 2. 3. 3A. 4. Trans. 5. Number of 6. Date Exercisable 7. Title and Amount of 8. Price 9. Number of 10. 11. Nature Derivate Conversion Trans. Deemed Code Derivative and Expiration Date Securities Underlying of derivative Ownership of Security or Date Execution (Instr. 8) Securities Derivative Security Derivative Securities Form of Indirect (Instr. 3) Exercise Date, if Acquired (A) or (Instr. 3 and 4) Security Beneficially Derivative Beneficial Price of any Disposed of (D) (Instr. 5) Owned Security: Ownership Derivative (Instr. 3, 4 Following Direct (D) (Instr. 4) Security and 5) Reported or Transaction(s) Indirect Date Expiration Amount or (Instr. 4) (I) Exercisable Date Title Number of (Instr. 4) Code V (A) (D) Shares Explanation of Responses: (1) These shares were issued as a restricted stock unit grant to the Reporting Person by the issuer under the issuer's 2016 Equity Incentive Plan. The restricted stock units vest in three equal annual installments beginning on March 21, 2022. (2) These securities are held by three trusts for the benefit of the Reporting Person's three children, respectively, and for which the Reporting Person serves as Trustee. Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other Kohavi Lior C/O CYREN INC., CSO & EVP, Advanced 1430 SPRING HILL ROAD, SUITE 330 Solutions MCLEAN, VA 22102 Signatures /s/ Lior Kohavi 4/21/2021 ** Signature of Reporting Person Date Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. * If the form is filed by more than one reporting person, see Instruction 4(b)(v). ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.